

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.61115460 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.61115460 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 6.18135146 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.13565436 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.13565436 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.13565436 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.13565436 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 6.13565436 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 6.13565436 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.81980695 |
| 11 | response to peptidoglycan (GO:0032494) | 5.81748352 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.63547189 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.55136469 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.05442545 |
| 15 | detection of other organism (GO:0098543) | 4.97496251 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.80676012 |
| 17 | detection of bacterium (GO:0016045) | 4.80425131 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.77254197 |
| 19 | positive regulation of interferon-alpha production (GO:0032727) | 4.72831245 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.71908466 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 4.62287070 |
| 22 | regulation of interferon-alpha production (GO:0032647) | 4.45917321 |
| 23 | respiratory burst (GO:0045730) | 4.38856315 |
| 24 | leukocyte aggregation (GO:0070486) | 4.37199655 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 4.34563775 |
| 26 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.33281706 |
| 27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.31841480 |
| 28 | granulocyte activation (GO:0036230) | 4.27541895 |
| 29 | detection of external biotic stimulus (GO:0098581) | 4.23277071 |
| 30 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.21528803 |
| 31 | neutrophil activation (GO:0042119) | 4.19522559 |
| 32 | response to interleukin-15 (GO:0070672) | 4.09812937 |
| 33 | response to host immune response (GO:0052572) | 4.08170287 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.08170287 |
| 35 | regulation of activation of Janus kinase activity (GO:0010533) | 4.05651163 |
| 36 | microglial cell activation (GO:0001774) | 3.96400403 |
| 37 | negative regulation of interleukin-17 production (GO:0032700) | 3.92852403 |
| 38 | positive regulation of mast cell activation (GO:0033005) | 3.92687017 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 3.92405440 |
| 40 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.91602465 |
| 41 | response to muramyl dipeptide (GO:0032495) | 3.89046461 |
| 42 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.88977083 |
| 43 | superoxide anion generation (GO:0042554) | 3.87639866 |
| 44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.83039205 |
| 45 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.82730417 |
| 46 | positive regulation of antigen processing and presentation (GO:0002579) | 3.82656208 |
| 47 | cellular response to interleukin-15 (GO:0071350) | 3.79941291 |
| 48 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.78878419 |
| 49 | natural killer cell mediated immunity (GO:0002228) | 3.78878419 |
| 50 | negative regulation of T cell mediated immunity (GO:0002710) | 3.73251305 |
| 51 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.72035983 |
| 52 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.72006618 |
| 53 | detection of biotic stimulus (GO:0009595) | 3.70095580 |
| 54 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.66322308 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.62521191 |
| 56 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.61185584 |
| 57 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.60783771 |
| 58 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.60676273 |
| 59 | positive regulation of mast cell degranulation (GO:0043306) | 3.60676273 |
| 60 | regulation of T cell tolerance induction (GO:0002664) | 3.60631519 |
| 61 | B cell receptor signaling pathway (GO:0050853) | 3.58853875 |
| 62 | response to host (GO:0075136) | 3.57296736 |
| 63 | response to host defenses (GO:0052200) | 3.57296736 |
| 64 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.57296736 |
| 65 | detection of molecule of bacterial origin (GO:0032490) | 3.57086324 |
| 66 | lymphocyte chemotaxis (GO:0048247) | 3.56715417 |
| 67 | regulation of mast cell activation (GO:0033003) | 3.53545311 |
| 68 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.53096640 |
| 69 | negative thymic T cell selection (GO:0045060) | 3.52743364 |
| 70 | regulation of B cell differentiation (GO:0045577) | 3.50938928 |
| 71 | T-helper 1 type immune response (GO:0042088) | 3.50592959 |
| 72 | regulation of mast cell degranulation (GO:0043304) | 3.49524722 |
| 73 | B cell mediated immunity (GO:0019724) | 3.48936693 |
| 74 | positive thymic T cell selection (GO:0045059) | 3.47622647 |
| 75 | macrophage activation (GO:0042116) | 3.47290144 |
| 76 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.45957880 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 3.45932898 |
| 78 | negative T cell selection (GO:0043383) | 3.45724994 |
| 79 | defense response to protozoan (GO:0042832) | 3.45300637 |
| 80 | leukocyte mediated cytotoxicity (GO:0001909) | 3.44580521 |
| 81 | positive regulation of interferon-beta production (GO:0032728) | 3.43718848 |
| 82 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.42547784 |
| 83 | regulation of tolerance induction (GO:0002643) | 3.41216265 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.40694800 |
| 85 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.40394297 |
| 86 | regulation of mononuclear cell migration (GO:0071675) | 3.38899204 |
| 87 | regulation of interleukin-17 production (GO:0032660) | 3.38365022 |
| 88 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.36483066 |
| 89 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.36004041 |
| 90 | positive regulation of interleukin-12 production (GO:0032735) | 3.34676495 |
| 91 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.34379170 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 3.31758220 |
| 93 | cellular response to exogenous dsRNA (GO:0071360) | 3.30461984 |
| 94 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.29742073 |
| 95 | positive regulation of lymphocyte migration (GO:2000403) | 3.28335454 |
| 96 | cellular extravasation (GO:0045123) | 3.27821897 |
| 97 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.27404402 |
| 98 | leukocyte degranulation (GO:0043299) | 3.26654283 |
| 99 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.25921667 |
| 100 | negative regulation of phagocytosis (GO:0050765) | 3.25540912 |
| 101 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.25315420 |
| 102 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.25143436 |
| 103 | regulation of leukocyte degranulation (GO:0043300) | 3.24621470 |
| 104 | neutrophil mediated immunity (GO:0002446) | 3.22508419 |
| 105 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.21261573 |
| 106 | type I interferon signaling pathway (GO:0060337) | 3.20848149 |
| 107 | cellular response to type I interferon (GO:0071357) | 3.20848149 |
| 108 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.20493290 |
| 109 | positive regulation of interleukin-17 production (GO:0032740) | 3.20249958 |
| 110 | reactive oxygen species biosynthetic process (GO:1903409) | 3.19544913 |
| 111 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.18969347 |
| 112 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.18398222 |
| 113 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.18398222 |
| 114 | activated T cell proliferation (GO:0050798) | 3.16081945 |
| 115 | response to type I interferon (GO:0034340) | 3.15161211 |
| 116 | germinal center formation (GO:0002467) | 3.14583486 |
| 117 | tolerance induction (GO:0002507) | 3.12345788 |
| 118 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.11648713 |
| 119 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.11125764 |
| 120 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.11087032 |
| 121 | negative regulation of mast cell activation (GO:0033004) | 3.10453844 |
| 122 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.10264273 |
| 123 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.09123295 |
| 124 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.09113316 |
| 125 | myeloid dendritic cell differentiation (GO:0043011) | 3.08363190 |
| 126 | positive regulation of T cell migration (GO:2000406) | 3.07270267 |
| 127 | T cell selection (GO:0045058) | 3.06844285 |
| 128 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.05707763 |
| 129 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.05707763 |
| 130 | regulation of monocyte chemotaxis (GO:0090025) | 3.04542262 |
| 131 | myeloid dendritic cell activation (GO:0001773) | 3.04422363 |
| 132 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04373651 |
| 133 | myeloid leukocyte activation (GO:0002274) | 3.04319628 |
| 134 | myeloid leukocyte mediated immunity (GO:0002444) | 3.04253242 |
| 135 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.03515777 |
| 136 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.03377395 |
| 137 | positive T cell selection (GO:0043368) | 3.03255984 |
| 138 | negative regulation of interleukin-6 production (GO:0032715) | 3.02333357 |
| 139 | regulation of regulatory T cell differentiation (GO:0045589) | 3.01990958 |
| 140 | lymphocyte mediated immunity (GO:0002449) | 3.01254242 |
| 141 | negative regulation of innate immune response (GO:0045824) | 3.00999613 |
| 142 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.00305868 |
| 143 | T cell migration (GO:0072678) | 3.00009103 |
| 144 | I-kappaB phosphorylation (GO:0007252) | 2.99668500 |
| 145 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.97539592 |
| 146 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.96256180 |
| 147 | monocyte chemotaxis (GO:0002548) | 2.95774200 |
| 148 | cellular response to interferon-beta (GO:0035458) | 2.94783885 |
| 149 | eosinophil chemotaxis (GO:0048245) | 2.94338587 |
| 150 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.92056218 |
| 151 | positive regulation of interleukin-10 production (GO:0032733) | 2.91011172 |
| 152 | response to protozoan (GO:0001562) | 2.90974207 |
| 153 | negative regulation of interleukin-12 production (GO:0032695) | 2.90374410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.15920631 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.88227070 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.69142585 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.83837858 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.49102799 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.24473796 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.16218335 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.87019074 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44737230 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.26965251 |
| 11 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.07166279 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.05541786 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.96144259 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.90112447 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.76638981 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73356966 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44967658 |
| 18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.35375272 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.24049364 |
| 20 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.20911123 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.16094611 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.13868366 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.09495408 |
| 24 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.95026749 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.89414823 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.87554449 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.83170915 |
| 28 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.82548099 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.80073446 |
| 30 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.77008663 |
| 31 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.76219869 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76180913 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72109915 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69174766 |
| 35 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.65647506 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62296616 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62141856 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61608972 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61519825 |
| 40 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60140047 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60038813 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58205660 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53095328 |
| 44 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.53069575 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51540917 |
| 46 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.50704546 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.47451970 |
| 48 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47165664 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.45707191 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42554418 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39509835 |
| 52 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36822110 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35708074 |
| 54 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.31327563 |
| 55 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28622303 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27962529 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27865355 |
| 58 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24268521 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22204316 |
| 60 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20034880 |
| 61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19829050 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18848611 |
| 63 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18784312 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18780615 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.18324281 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15776253 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14178888 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13586542 |
| 69 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13221927 |
| 70 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.12447771 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09178220 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08451855 |
| 73 | MAF_26560356_Chip-Seq_TH1_Human | 1.08093713 |
| 74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07069679 |
| 75 | MYB_26560356_Chip-Seq_TH1_Human | 1.05819759 |
| 76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05213686 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03978779 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03821469 |
| 79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02358259 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00085239 |
| 81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99120318 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98772689 |
| 83 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.98746195 |
| 84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.97262997 |
| 85 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93747077 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91547020 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91186833 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91116391 |
| 89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91055715 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90106798 |
| 91 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89508480 |
| 92 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.88211267 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86882308 |
| 94 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86488562 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86407810 |
| 96 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84632595 |
| 97 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.84513111 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82734662 |
| 99 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.80412404 |
| 100 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79350017 |
| 101 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.75851485 |
| 102 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.74272412 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72848240 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71781047 |
| 105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71781047 |
| 106 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.69773155 |
| 107 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69700337 |
| 108 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.69269836 |
| 109 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.67927013 |
| 110 | UTX_26944678_Chip-Seq_JUKART_Human | 0.66634750 |
| 111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66121419 |
| 112 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.61439772 |
| 113 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.61279797 |
| 114 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.60298058 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.59882888 |
| 116 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.58371195 |
| 117 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.58136173 |
| 118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.56650405 |
| 119 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.56482282 |
| 120 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.55886324 |
| 121 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.55886324 |
| 122 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.55488550 |
| 123 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.55443712 |
| 124 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.54126972 |
| 125 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.53910917 |
| 126 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.53025997 |
| 127 | MAF_26560356_Chip-Seq_TH2_Human | 0.51626078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.12541497 |
| 2 | MP0003436_decreased_susceptibility_to | 4.19094054 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 4.05774340 |
| 4 | MP0009785_altered_susceptibility_to | 3.89779723 |
| 5 | MP0002419_abnormal_innate_immunity | 3.51769750 |
| 6 | MP0006082_CNS_inflammation | 3.45415471 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.43057282 |
| 8 | MP0005058_abnormal_lysosome_morphology | 3.30139464 |
| 9 | MP0005025_abnormal_response_to | 3.16979443 |
| 10 | MP0003303_peritoneal_inflammation | 2.89796334 |
| 11 | MP0003724_increased_susceptibility_to | 2.87215441 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.75164577 |
| 13 | MP0005671_abnormal_response_to | 2.67499217 |
| 14 | MP0005387_immune_system_phenotype | 2.66645577 |
| 15 | MP0001790_abnormal_immune_system | 2.66645577 |
| 16 | MP0002723_abnormal_immune_serum | 2.55491550 |
| 17 | MP0001800_abnormal_humoral_immune | 2.53094065 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.52668484 |
| 19 | MP0000685_abnormal_immune_system | 2.45568912 |
| 20 | MP0000569_abnormal_digit_pigmentation | 2.43585429 |
| 21 | MP0001819_abnormal_immune_cell | 2.29515259 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.25698329 |
| 23 | MP0004510_myositis | 2.18233108 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.11280490 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.07988135 |
| 26 | MP0002405_respiratory_system_inflammati | 2.05574146 |
| 27 | MP0003448_altered_tumor_morphology | 1.96420600 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.89717295 |
| 29 | MP0005310_abnormal_salivary_gland | 1.80383719 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.78953586 |
| 31 | MP0009764_decreased_sensitivity_to | 1.77697225 |
| 32 | MP0004947_skin_inflammation | 1.72515494 |
| 33 | MP0000343_altered_response_to | 1.69234683 |
| 34 | MP0001853_heart_inflammation | 1.68748035 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.67203557 |
| 36 | MP0008469_abnormal_protein_level | 1.64940557 |
| 37 | MP0003075_altered_response_to | 1.62809845 |
| 38 | MP0002006_tumorigenesis | 1.60469744 |
| 39 | MP0000716_abnormal_immune_system | 1.57074445 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.54203386 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.54028569 |
| 42 | MP0000703_abnormal_thymus_morphology | 1.53145480 |
| 43 | MP0009278_abnormal_bone_marrow | 1.52896784 |
| 44 | MP0003690_abnormal_glial_cell | 1.51844746 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.44848306 |
| 46 | MP0002398_abnormal_bone_marrow | 1.43083239 |
| 47 | MP0000604_amyloidosis | 1.40308913 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.38349088 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.38349088 |
| 50 | MP0008260_abnormal_autophagy | 1.35764399 |
| 51 | MP0000858_altered_metastatic_potential | 1.34226388 |
| 52 | MP0005166_decreased_susceptibility_to | 1.32846563 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.27010780 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.25528001 |
| 55 | MP0002429_abnormal_blood_cell | 1.24499755 |
| 56 | MP0000015_abnormal_ear_pigmentation | 1.23633630 |
| 57 | MP0004782_abnormal_surfactant_physiolog | 1.22920710 |
| 58 | MP0003828_pulmonary_edema | 1.20477410 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.19196626 |
| 60 | MP0009840_abnormal_foam_cell | 1.17288395 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.13134122 |
| 62 | MP0002722_abnormal_immune_system | 1.12580205 |
| 63 | MP0005257_abnormal_intraocular_pressure | 1.07121306 |
| 64 | MP0009763_increased_sensitivity_to | 1.04006660 |
| 65 | MP0002166_altered_tumor_susceptibility | 1.01655005 |
| 66 | MP0005390_skeleton_phenotype | 1.00747368 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 0.97404752 |
| 68 | MP0010307_abnormal_tumor_latency | 0.93726241 |
| 69 | MP0000371_diluted_coat_color | 0.91772165 |
| 70 | MP0001986_abnormal_taste_sensitivity | 0.90903302 |
| 71 | MP0001851_eye_inflammation | 0.89588245 |
| 72 | MP0005167_abnormal_blood-brain_barrier | 0.89543935 |
| 73 | MP0003566_abnormal_cell_adhesion | 0.89407866 |
| 74 | MP0008004_abnormal_stomach_pH | 0.88788050 |
| 75 | MP0003186_abnormal_redox_activity | 0.87062861 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.86925232 |
| 77 | MP0002933_joint_inflammation | 0.86848916 |
| 78 | MP0002132_abnormal_respiratory_system | 0.83619355 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 0.82427658 |
| 80 | MP0005164_abnormal_response_to | 0.81604637 |
| 81 | MP0000249_abnormal_blood_vessel | 0.80007437 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.79757200 |
| 83 | MP0010386_abnormal_urinary_bladder | 0.79524270 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.75913567 |
| 85 | MP0000490_abnormal_crypts_of | 0.75292622 |
| 86 | MP0004130_abnormal_muscle_cell | 0.68525492 |
| 87 | MP0000920_abnormal_myelination | 0.68053201 |
| 88 | MP0003795_abnormal_bone_structure | 0.67166799 |
| 89 | MP0003300_gastrointestinal_ulcer | 0.66517747 |
| 90 | MP0005171_absent_coat_pigmentation | 0.63700774 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.63584988 |
| 92 | MP0004883_abnormal_blood_vessel | 0.62950900 |
| 93 | MP0003763_abnormal_thymus_physiology | 0.62229908 |
| 94 | MP0008874_decreased_physiological_sensi | 0.61237048 |
| 95 | MP0003045_fibrosis | 0.60756676 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.60318217 |
| 97 | MP0003136_yellow_coat_color | 0.59207670 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.59070894 |
| 99 | MP0003091_abnormal_cell_migration | 0.56210696 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.55487250 |
| 101 | MP0001873_stomach_inflammation | 0.53135451 |
| 102 | MP0000372_irregular_coat_pigmentation | 0.53072835 |
| 103 | MP0001663_abnormal_digestive_system | 0.51877007 |
| 104 | MP0000767_abnormal_smooth_muscle | 0.51104527 |
| 105 | MP0002019_abnormal_tumor_incidence | 0.50307301 |
| 106 | MP0003866_abnormal_defecation | 0.49872709 |
| 107 | MP0005451_abnormal_body_composition | 0.49503321 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.49183357 |
| 109 | MP0002693_abnormal_pancreas_physiology | 0.48863518 |
| 110 | MP0005197_abnormal_uvea_morphology | 0.48527260 |
| 111 | MP0003453_abnormal_keratinocyte_physiol | 0.47744714 |
| 112 | MP0002009_preneoplasia | 0.47491434 |
| 113 | MP0005377_hearing/vestibular/ear_phenot | 0.47397906 |
| 114 | MP0003878_abnormal_ear_physiology | 0.47397906 |
| 115 | MP0004808_abnormal_hematopoietic_stem | 0.47284551 |
| 116 | MP0005381_digestive/alimentary_phenotyp | 0.45958703 |
| 117 | MP0004381_abnormal_hair_follicle | 0.45022311 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.45021323 |
| 119 | MP0002928_abnormal_bile_duct | 0.44900821 |
| 120 | MP0002133_abnormal_respiratory_system | 0.44459963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 8.09212190 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 7.06257611 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.78861925 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.30416096 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 5.51967154 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.38369123 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 5.22013780 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.85472950 |
| 9 | Gingivitis (HP:0000230) | 4.54955899 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 4.43253210 |
| 11 | Recurrent skin infections (HP:0001581) | 4.30797182 |
| 12 | Obstructive lung disease (HP:0006536) | 4.26628255 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 4.26628255 |
| 14 | Stomatitis (HP:0010280) | 4.24202617 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.20693240 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 4.16788831 |
| 17 | Optic neuritis (HP:0100653) | 4.16788831 |
| 18 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.16420928 |
| 19 | Prostate neoplasm (HP:0100787) | 4.12161125 |
| 20 | Myositis (HP:0100614) | 4.08707793 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.06542585 |
| 22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.06542585 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 4.06542585 |
| 24 | Orchitis (HP:0100796) | 4.00407245 |
| 25 | Encephalitis (HP:0002383) | 3.90236536 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.86747488 |
| 27 | Spontaneous hematomas (HP:0007420) | 3.77199710 |
| 28 | Glomerulonephritis (HP:0000099) | 3.68289445 |
| 29 | Increased IgE level (HP:0003212) | 3.66682820 |
| 30 | Recurrent fungal infections (HP:0002841) | 3.65882241 |
| 31 | Hypochromic microcytic anemia (HP:0004840) | 3.64830514 |
| 32 | Periodontitis (HP:0000704) | 3.46834353 |
| 33 | T lymphocytopenia (HP:0005403) | 3.44645236 |
| 34 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.41115186 |
| 35 | Axonal loss (HP:0003447) | 3.38952377 |
| 36 | Pustule (HP:0200039) | 3.34797057 |
| 37 | Disinhibition (HP:0000734) | 3.33607728 |
| 38 | Autoimmune thrombocytopenia (HP:0001973) | 3.32114504 |
| 39 | Agnosia (HP:0010524) | 3.31079793 |
| 40 | Abnormality of T cell number (HP:0011839) | 3.30457011 |
| 41 | Thick nail (HP:0001805) | 3.28104442 |
| 42 | Chest pain (HP:0100749) | 3.26867146 |
| 43 | Hypochromic anemia (HP:0001931) | 3.26136618 |
| 44 | Vasculitis (HP:0002633) | 3.19167490 |
| 45 | Dysostosis multiplex (HP:0000943) | 3.11602515 |
| 46 | Episodic fever (HP:0001954) | 3.09505891 |
| 47 | Basal ganglia calcification (HP:0002135) | 3.01879017 |
| 48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.98969735 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.98969735 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.98745913 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.93167568 |
| 52 | Abnormality of T cells (HP:0002843) | 2.89392601 |
| 53 | Gastrointestinal inflammation (HP:0004386) | 2.82836087 |
| 54 | Recurrent viral infections (HP:0004429) | 2.79864614 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.79674065 |
| 56 | Increased IgM level (HP:0003496) | 2.79136856 |
| 57 | Pulmonary embolism (HP:0002204) | 2.76125196 |
| 58 | Mucopolysacchariduria (HP:0008155) | 2.74216382 |
| 59 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.74216382 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.70141174 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.70141174 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.70141174 |
| 63 | Recurrent pneumonia (HP:0006532) | 2.69276067 |
| 64 | Granulocytopenia (HP:0001913) | 2.67380703 |
| 65 | Hepatosplenomegaly (HP:0001433) | 2.67369372 |
| 66 | Gastrointestinal infarctions (HP:0005244) | 2.65826233 |
| 67 | Meningitis (HP:0001287) | 2.65685503 |
| 68 | Cellulitis (HP:0100658) | 2.63815621 |
| 69 | Urticaria (HP:0001025) | 2.60137913 |
| 70 | Poor head control (HP:0002421) | 2.57435669 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.53274549 |
| 72 | Peritonitis (HP:0002586) | 2.53197392 |
| 73 | Lymphopenia (HP:0001888) | 2.52953200 |
| 74 | Amyloidosis (HP:0011034) | 2.52786352 |
| 75 | Loss of speech (HP:0002371) | 2.51084653 |
| 76 | Abnormality of the prostate (HP:0008775) | 2.48022365 |
| 77 | Microcytic anemia (HP:0001935) | 2.47308720 |
| 78 | Nephritis (HP:0000123) | 2.45751378 |
| 79 | Leukocytosis (HP:0001974) | 2.44427565 |
| 80 | Osteomyelitis (HP:0002754) | 2.43426623 |
| 81 | Purpura (HP:0000979) | 2.43275154 |
| 82 | Hemoptysis (HP:0002105) | 2.39807430 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 2.38072383 |
| 84 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.37762386 |
| 85 | Abnormality of complement system (HP:0005339) | 2.37464072 |
| 86 | Agammaglobulinemia (HP:0004432) | 2.36321011 |
| 87 | Colitis (HP:0002583) | 2.34661510 |
| 88 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.34646870 |
| 89 | Myocardial infarction (HP:0001658) | 2.33556441 |
| 90 | Arterial thrombosis (HP:0004420) | 2.32372789 |
| 91 | Pathologic fracture (HP:0002756) | 2.30677395 |
| 92 | Keratoconjunctivitis sicca (HP:0001097) | 2.30216055 |
| 93 | Upper motor neuron abnormality (HP:0002127) | 2.29129935 |
| 94 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.25164540 |
| 95 | IgM deficiency (HP:0002850) | 2.22875834 |
| 96 | Osteolytic defects of the hand bones (HP:0009699) | 2.21350144 |
| 97 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.21350144 |
| 98 | Recurrent lower respiratory tract infections (HP:0002783) | 2.20257165 |
| 99 | Premature loss of primary teeth (HP:0006323) | 2.19513626 |
| 100 | Joint hemorrhage (HP:0005261) | 2.19146572 |
| 101 | Glomerulopathy (HP:0100820) | 2.16038814 |
| 102 | Bone pain (HP:0002653) | 2.12047738 |
| 103 | Abnormality of the peritoneum (HP:0002585) | 2.11921044 |
| 104 | Gingival bleeding (HP:0000225) | 2.10556822 |
| 105 | Increased serum ferritin (HP:0003281) | 2.09643563 |
| 106 | Petechiae (HP:0000967) | 2.09360200 |
| 107 | Anorexia (HP:0002039) | 2.09219447 |
| 108 | Keratoconjunctivitis (HP:0001096) | 2.08119390 |
| 109 | J-shaped sella turcica (HP:0002680) | 2.07388939 |
| 110 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.05779667 |
| 111 | Vertigo (HP:0002321) | 2.03476817 |
| 112 | Autoimmune hemolytic anemia (HP:0001890) | 2.03363468 |
| 113 | Abnormality of eosinophils (HP:0001879) | 2.02375702 |
| 114 | Keratitis (HP:0000491) | 2.02122640 |
| 115 | Abnormality of the endocardium (HP:0004306) | 2.02084225 |
| 116 | Albinism (HP:0001022) | 2.02081323 |
| 117 | Acne (HP:0001061) | 1.99917376 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 1.99346584 |
| 119 | Slow saccadic eye movements (HP:0000514) | 1.97719214 |
| 120 | Progressive visual loss (HP:0000529) | 1.97388976 |
| 121 | Recurrent bronchitis (HP:0002837) | 1.96259641 |
| 122 | Acute hepatic failure (HP:0006554) | 1.96099262 |
| 123 | Chronic otitis media (HP:0000389) | 1.95222195 |
| 124 | Viral hepatitis (HP:0006562) | 1.95037631 |
| 125 | Recurrent sinusitis (HP:0011108) | 1.92184219 |
| 126 | Gangrene (HP:0100758) | 1.90347572 |
| 127 | Cheilitis (HP:0100825) | 1.90104598 |
| 128 | Hypergammaglobulinemia (HP:0010702) | 1.89356778 |
| 129 | Abnormal platelet volume (HP:0011876) | 1.87339852 |
| 130 | Arthralgia (HP:0002829) | 1.83094009 |
| 131 | Tetraparesis (HP:0002273) | 1.82688635 |
| 132 | Abnormality of the lumbar spine (HP:0100712) | 1.78887409 |
| 133 | Inappropriate behavior (HP:0000719) | 1.74645361 |
| 134 | Abnormality of the pleura (HP:0002103) | 1.73584245 |
| 135 | Epistaxis (HP:0000421) | 1.72949204 |
| 136 | Skin ulcer (HP:0200042) | 1.72059812 |
| 137 | Eosinophilia (HP:0001880) | 1.69284475 |
| 138 | Diminished motivation (HP:0000745) | 1.68886294 |
| 139 | Apathy (HP:0000741) | 1.67924991 |
| 140 | Polyneuropathy (HP:0001271) | 1.66729727 |
| 141 | Prolonged bleeding time (HP:0003010) | 1.65890637 |
| 142 | Sepsis (HP:0100806) | 1.65296130 |
| 143 | Abnormality of the pericardium (HP:0001697) | 1.64839452 |
| 144 | Personality changes (HP:0000751) | 1.64476243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.75253974 |
| 2 | MAP3K14 | 4.73015508 |
| 3 | BLK | 4.48283954 |
| 4 | PBK | 3.65091134 |
| 5 | IRAK4 | 3.58234265 |
| 6 | IRAK3 | 3.43643329 |
| 7 | TBK1 | 3.03927598 |
| 8 | TYK2 | 2.80239301 |
| 9 | MAP3K13 | 2.50256507 |
| 10 | TNK2 | 2.47392514 |
| 11 | MAP4K1 | 2.44366633 |
| 12 | GRK6 | 2.43634900 |
| 13 | TXK | 2.35858307 |
| 14 | IKBKB | 2.35234337 |
| 15 | KIT | 2.13946680 |
| 16 | JAK3 | 2.12530967 |
| 17 | IKBKE | 1.96911093 |
| 18 | NEK9 | 1.86824733 |
| 19 | NME2 | 1.85007153 |
| 20 | PIM2 | 1.82218040 |
| 21 | TAOK1 | 1.79184099 |
| 22 | BMPR2 | 1.69458630 |
| 23 | JAK1 | 1.62937742 |
| 24 | TAOK3 | 1.62557225 |
| 25 | HCK | 1.45718793 |
| 26 | SYK | 1.44995086 |
| 27 | LYN | 1.35167450 |
| 28 | FGR | 1.35161724 |
| 29 | CSK | 1.34301328 |
| 30 | CSF1R | 1.33996161 |
| 31 | CHUK | 1.32114237 |
| 32 | GRK7 | 1.31807523 |
| 33 | TEC | 1.29267273 |
| 34 | ZAP70 | 1.23483223 |
| 35 | BTK | 1.21018584 |
| 36 | ERBB3 | 1.19125453 |
| 37 | PIM1 | 1.13908783 |
| 38 | JAK2 | 1.10173206 |
| 39 | YES1 | 1.08715947 |
| 40 | LCK | 1.08193909 |
| 41 | KSR2 | 1.06438015 |
| 42 | ABL2 | 1.05979603 |
| 43 | MARK3 | 1.05249791 |
| 44 | ARAF | 1.04002551 |
| 45 | EIF2AK2 | 1.01478879 |
| 46 | FES | 1.00325383 |
| 47 | ADRBK2 | 1.00006368 |
| 48 | STK4 | 0.99421567 |
| 49 | RPS6KA4 | 0.99386134 |
| 50 | MARK2 | 0.97873348 |
| 51 | ZAK | 0.96516110 |
| 52 | TESK2 | 0.96435515 |
| 53 | EPHB1 | 0.92829149 |
| 54 | PRKD2 | 0.92824102 |
| 55 | TRPM7 | 0.91362775 |
| 56 | TGFBR2 | 0.86650719 |
| 57 | MATK | 0.84036842 |
| 58 | PRKCD | 0.83063246 |
| 59 | MST4 | 0.82455642 |
| 60 | PTK6 | 0.81180222 |
| 61 | SIK3 | 0.79806083 |
| 62 | MST1R | 0.79418873 |
| 63 | MAP2K3 | 0.78499150 |
| 64 | TRIB3 | 0.77064705 |
| 65 | CDK19 | 0.73401327 |
| 66 | MAP3K12 | 0.72367989 |
| 67 | MAPK12 | 0.70454167 |
| 68 | BMPR1B | 0.70020692 |
| 69 | MAP3K7 | 0.69105376 |
| 70 | ABL1 | 0.68490783 |
| 71 | IRAK1 | 0.68401189 |
| 72 | STK10 | 0.67226459 |
| 73 | LRRK2 | 0.65587217 |
| 74 | IRAK2 | 0.64411022 |
| 75 | DYRK1B | 0.63839501 |
| 76 | CDC42BPA | 0.61834972 |
| 77 | CAMKK2 | 0.61666108 |
| 78 | CLK1 | 0.59582755 |
| 79 | BMX | 0.59109538 |
| 80 | MOS | 0.58791949 |
| 81 | MAPK7 | 0.58558705 |
| 82 | PTK2B | 0.57699432 |
| 83 | CAMKK1 | 0.57605313 |
| 84 | HIPK2 | 0.56951665 |
| 85 | EGFR | 0.56757760 |
| 86 | TAOK2 | 0.56576166 |
| 87 | MAP3K5 | 0.54328701 |
| 88 | TLK1 | 0.54246122 |
| 89 | ERN1 | 0.52185452 |
| 90 | SIK2 | 0.52180613 |
| 91 | SMG1 | 0.50084889 |
| 92 | EPHA3 | 0.49737440 |
| 93 | STK11 | 0.49637802 |
| 94 | SGK3 | 0.49407324 |
| 95 | ITK | 0.48096831 |
| 96 | MAP3K2 | 0.48069636 |
| 97 | PRKCQ | 0.45627056 |
| 98 | MAP3K3 | 0.45308511 |
| 99 | SIK1 | 0.44945117 |
| 100 | MAP3K11 | 0.44541134 |
| 101 | PIK3CG | 0.42807289 |
| 102 | RPS6KC1 | 0.41804280 |
| 103 | RPS6KL1 | 0.41804280 |
| 104 | STK38 | 0.40107312 |
| 105 | FGFR4 | 0.40095562 |
| 106 | PRPF4B | 0.39104436 |
| 107 | RAF1 | 0.38504527 |
| 108 | MAP2K6 | 0.38447048 |
| 109 | MAP3K6 | 0.38345926 |
| 110 | MAPKAPK2 | 0.37925166 |
| 111 | FYN | 0.35560052 |
| 112 | MAP2K4 | 0.34911887 |
| 113 | DAPK3 | 0.33367600 |
| 114 | RET | 0.33324145 |
| 115 | MAP2K2 | 0.31956453 |
| 116 | FGFR3 | 0.30486830 |
| 117 | CDK4 | 0.29280605 |
| 118 | SGK2 | 0.28249863 |
| 119 | PKN1 | 0.28009723 |
| 120 | GRK1 | 0.27917257 |
| 121 | NLK | 0.27521206 |
| 122 | PRKCH | 0.26998299 |
| 123 | DAPK2 | 0.25372320 |
| 124 | CAMK1D | 0.25207590 |
| 125 | PLK4 | 0.24344598 |
| 126 | IGF1R | 0.23003188 |
| 127 | ACVR1B | 0.21438475 |
| 128 | DAPK1 | 0.21160607 |
| 129 | MAP3K1 | 0.20645575 |
| 130 | RPS6KA6 | 0.19973688 |
| 131 | TTN | 0.19385566 |
| 132 | STK3 | 0.19179289 |
| 133 | PAK4 | 0.18919497 |
| 134 | CDK6 | 0.18794934 |
| 135 | PLK2 | 0.14319833 |
| 136 | PDK1 | 0.14225491 |
| 137 | PDPK1 | 0.12313080 |
| 138 | RPS6KA5 | 0.11661772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.49880512 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.42613746 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.23806084 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.86896036 |
| 5 | Legionellosis_Homo sapiens_hsa05134 | 2.71272024 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.59862183 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.54727481 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.54493443 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.54150052 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.50749593 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 2.43186091 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.43044862 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37741145 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.25043713 |
| 15 | Malaria_Homo sapiens_hsa05144 | 2.21142578 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.20319789 |
| 17 | Phagosome_Homo sapiens_hsa04145 | 2.11806880 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 2.11096992 |
| 19 | Measles_Homo sapiens_hsa05162 | 2.04974257 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.03942940 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.02500402 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.87093333 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83949950 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.83126980 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.77410865 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.70047666 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.61389773 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58295391 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57147720 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46566763 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46555455 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44942685 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42593507 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40231851 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.39691216 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36039244 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.28154311 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25616331 |
| 39 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.22752187 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19003105 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.16080228 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14612913 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13685403 |
| 44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.08821451 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07522863 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97543447 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 0.95867387 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94752738 |
| 49 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.90672094 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.88893144 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86733947 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.85885330 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85670916 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84584649 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78004873 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.77903641 |
| 57 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.77652117 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74769648 |
| 59 | Prion diseases_Homo sapiens_hsa05020 | 0.69979736 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65730544 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65463634 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62975895 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62390400 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59989729 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58528733 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58335652 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57632827 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.56961938 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56678857 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56154386 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54929729 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54608758 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54460517 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49941141 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49280573 |
| 76 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48202870 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.47738160 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46078300 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45864634 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45603202 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45075836 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45036510 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45024053 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43144766 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.42632412 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42220713 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41880039 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41348390 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41168097 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41166876 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40770011 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.39615640 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38019900 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37204639 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36912955 |
| 96 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36615676 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34992074 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33055734 |
| 99 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32142088 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31809428 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30379635 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29916335 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28758735 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27684884 |
| 105 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.26258712 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26194341 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26083401 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22187446 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.21055901 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19322136 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.18543025 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.18411812 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18104439 |
| 114 | Homologous recombination_Homo sapiens_hsa03440 | 0.17565650 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.17089539 |
| 116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.17003666 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.16363328 |
| 118 | Proteasome_Homo sapiens_hsa03050 | 0.15985683 |
| 119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.13876187 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.12653082 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12607125 |
| 122 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.08628871 |
| 123 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.05457284 |

